glp 1 titration GLP-1 Agonists: A Comprehensive Overview GLP-1 receptor agonists in the

It was released as a blood glucose control treatment for patients with diabetes, but it was approved for use as an obesity treatment by the US Food and Drug Administration (FDA) in 2014, as it was found to be effective for weight loss without hypoglycemia in obese people who did not have diabetes

Nevertheless, technical complexity, ethical considerations, and potential immune responses remain major obstacles to clinical translation

Plasma cholesterol and depressive symptoms in older men Lancet 1993

For people on thyroid medication: TSH every three to six months during active weight loss if taking levothyroxine, as weight changes can affect thyroid hormone requirements